IQVIA Holdings Inc.

IQV trades at a P/E of 19.7 with RSI at 37.2, suggesting modest undervaluation relative to its industrial peer group and oversold momentum conditions. The stock sits meaningfully below its 52-week high, yet the depressed RSI indicates potential capitulation rather than structural weakness. At $28.1B market cap, this research services giant appears reasonably priced for a business with consistent contract flows, though the pullback may reflect broader sector rotation out of industrials or concerns about pharma client spending. The setup could attract contrarian value hunters, though confirmation of stabilizing demand metrics would strengthen conviction.